Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.14 USD | -2.16% | -9.56% | +0.12% |
Jun. 01 | Transcript : Iovance Biotherapeutics, Inc. - Special Call | |
May. 13 | Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.12% | 2.28B | |
-39.62% | 8.24B | |
+7.28% | 3.55B | |
-21.06% | 1.98B | |
-22.17% | 1.64B | |
+29.16% | 1.12B | |
+28.50% | 803M | |
-9.39% | 700M | |
-20.20% | 575M | |
-1.29% | 292M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Truist Adjusts Iovance Biotherapeutics' Price Target to $25 From $26, Keeps Buy Rating